Sicart Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,500
Closed -$531K 82
2018
Q3
$531K Hold
12,500
0.25% 58
2018
Q2
$515K Hold
12,500
0.27% 59
2018
Q1
$725K Hold
12,500
0.43% 50
2017
Q4
$684K Buy
12,500
+6,000
+92% +$306K 0.36% 60
2017
Q3
$330K Hold
6,500
0.24% 65
2017
Q2
$377K Hold
6,500
0.27% 62
2017
Q1
$380K Sell
6,500
-1,500
-19% -$85.1K 0.27% 69
2016
Q4
$445K Buy
+8,000
New +$428K 0.31% 77

Other funds holding ALKS

Sicart Associates's ALKS Position: Q4 2018 in Review

Sicart Associates sold out of Alkermes (ALKS) in Q4 2018, closing a stake of 12,500 shares — an estimated $531K sold.

Sicart Associates first reported a position in ALKS in Q4 2016 and held it in 8 quarters. The position peaked at $725K in Q1 2018. 238 funds tracked by Wall St. Rank hold ALKS as of Q4 2018.

  • Sicart Associates reported no remaining Alkermes position as of Q4 2018 after selling out during the quarter.
  • Sicart Associates sold 12,500 Alkermes shares in Q4 2018, an estimated $531K.
  • Sicart Associates first reported a position in Alkermes in Q4 2016 and held it in 8 quarters.
  • Sicart Associates's Alkermes position peaked at $725K in Q1 2018.
  • 238 funds tracked by Wall St. Rank held Alkermes as of Q4 2018.

Based on Sicart Associates's 13F filing for Q4 2018, filed 22 Jan 2019.